JP2023540733A5 - - Google Patents

Info

Publication number
JP2023540733A5
JP2023540733A5 JP2023514910A JP2023514910A JP2023540733A5 JP 2023540733 A5 JP2023540733 A5 JP 2023540733A5 JP 2023514910 A JP2023514910 A JP 2023514910A JP 2023514910 A JP2023514910 A JP 2023514910A JP 2023540733 A5 JP2023540733 A5 JP 2023540733A5
Authority
JP
Japan
Prior art keywords
disease
disorder
compound according
membered
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023514910A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540733A (ja
JP7865948B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/049001 external-priority patent/WO2022051582A1/en
Publication of JP2023540733A publication Critical patent/JP2023540733A/ja
Publication of JP2023540733A5 publication Critical patent/JP2023540733A5/ja
Application granted granted Critical
Publication of JP7865948B2 publication Critical patent/JP7865948B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023514910A 2020-09-04 2021-09-03 アルキルオキサシクロアルキル部分を含むスルファモイル尿素誘導体およびその使用 Active JP7865948B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063074521P 2020-09-04 2020-09-04
US63/074,521 2020-09-04
PCT/US2021/049001 WO2022051582A1 (en) 2020-09-04 2021-09-03 Sulphamoyl urea derivatives containing alkyl-oxacycloalkyl moiety and uses thereof

Publications (3)

Publication Number Publication Date
JP2023540733A JP2023540733A (ja) 2023-09-26
JP2023540733A5 true JP2023540733A5 (enExample) 2024-09-09
JP7865948B2 JP7865948B2 (ja) 2026-05-26

Family

ID=77951864

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023514910A Active JP7865948B2 (ja) 2020-09-04 2021-09-03 アルキルオキサシクロアルキル部分を含むスルファモイル尿素誘導体およびその使用

Country Status (13)

Country Link
US (1) US20240043410A1 (enExample)
EP (1) EP4208459A1 (enExample)
JP (1) JP7865948B2 (enExample)
KR (1) KR20230061505A (enExample)
CN (1) CN116783184A (enExample)
AR (1) AR123435A1 (enExample)
AU (1) AU2021336518B2 (enExample)
BR (1) BR112023003792A2 (enExample)
CA (1) CA3191410A1 (enExample)
IL (1) IL301055A (enExample)
MX (1) MX2023002686A (enExample)
TW (1) TWI916398B (enExample)
WO (1) WO2022051582A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
HUE067378T2 (hu) 2019-06-12 2024-10-28 Nodthera Ltd Szulfonilurea származékok és alkalmazásaik
JP7661248B2 (ja) 2019-06-12 2025-04-14 ノッドセラ リミテッド スルホニル尿素誘導体及びその使用
KR20260115622A (ko) * 2023-11-17 2026-07-24 노드테라 리미티드 우레아 유도체의 제조 방법
CN122555701A (zh) 2023-11-17 2026-08-11 诺瑟拉有限公司 脲衍生物的形式和相关用途
TW202545527A (zh) * 2024-01-16 2025-12-01 英商諾得瑟拉公司 Nlrp3及glp-1a組合療法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
DK1270565T3 (da) 1997-01-29 2004-10-04 Pfizer 4-substitueret furan-2-sulfonamid og dets anvendelse i fremstillingen af sulfonylurinstofderivater
JP6929792B2 (ja) * 2015-02-16 2021-09-01 ザ ユニバーシティ オブ クィーンズランド スルホニル尿素及び関連化合物並びにその使用
JP7412328B2 (ja) 2017-07-24 2024-01-12 ノバルティス アーゲー Nlrp活性に関連する状態を治療するための化合物及び組成物
GB201721185D0 (en) * 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
SG11202101480XA (en) 2018-08-15 2021-03-30 Inflazome Ltd Novel sulfonamideurea compounds

Similar Documents

Publication Publication Date Title
KR102833881B1 (ko) 바이러스 감염 치료를 위한 화합물 및 방법
JP2022536160A5 (enExample)
JP2020528889A5 (enExample)
JP2019519598A5 (enExample)
JP6553551B2 (ja) B型肝炎抗ウイルス剤
JP2022505525A5 (enExample)
JP2018531289A5 (enExample)
JP2022507506A5 (enExample)
EA020749B1 (ru) Вич-ингибирующие 5,6-замещенные пиримидины
HRP20250964T1 (hr) Derivati sulfonil ureje kao modulatori nlrp3 inflamasoma
JP2025524640A (ja) Nlrp3インフラマソーム経路の調節剤としてのピロロトリアジン及びイミダゾトリアジン誘導体
JP2022535956A5 (enExample)
JP2022535955A5 (enExample)
JP2022506898A5 (enExample)
CN117940120A (zh) 化合物、组合物和方法
AU2022366992A1 (en) Integrin inhibitors and uses thereof in combination with other agents
ES2895965T3 (es) Moduladores del receptor de GABA(A) y métodos para controlar la hiperreactividad de las vías respiratorias y la inflamación en el asma
JP2022522890A5 (enExample)
HRP20240896T1 (hr) Derivati sulfoniluree i njihova upotreba
ES3028099T3 (en) Polymorphic carbazole derivatives and uses thereof
ES2707675T3 (es) Inhibidores de la replicación viral, su proceso de preparación y sus usos terapéuticos
US20140342989A1 (en) Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
JP2025504374A5 (enExample)
JP2022518526A5 (enExample)
JP2020518621A5 (enExample)